After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis
GLP-1 is an incretin hormone secreted by the intestine after food intake
People with a history of disordered eating, particularly restrictive eating disorders such as anorexia or orthorexia, should be cautious about both semaglutide-driven appetite suppression and the rigid food rules inherent in ketogenic eating
Study Details | A Study of Tirzepatide (LY
Some protocols recommend waiting longer, up to 2 weeks, particularly for patients transitioning from high tirzepatide doses (12.5 mg or 15 mg) to reduce the overlap of active drug and minimize initial side effects
The long-term maintenance benefit is perhaps the most underappreciated advantage of building fat-adapted metabolism while pharmaceutical appetite suppression is supporting adherence